XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Pay vs Performance Disclosure - USD ($)
1 Months Ended 11 Months Ended 12 Months Ended
Jan. 16, 2024
Dec. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Pay vs Performance Disclosure          
Pay vs Performance Disclosure, Table    

Value of

 

PEO (Dr. Walker)

PEO (Dr. Manion)

Average

Average

Initial Fixed

 

Summary

Summary

Summary

Compensation

$100 Investment 

 

Compensation

Compensation

Compensation

Compensation

Compensation

Actually Paid to

Based on: Total

 

Table Total

Actually

Table Total

Actually

Total for

Non-PEO 

Shareholder

 

Year

    

for PEO(1)(2)

    

Paid to PEO(1)(3)

    

for PEO(1)(2)

    

Paid to PEO(1)(3)

    

Non-PEO NEOs(1)(2)

    

NEOs(1) (3)

    

Return(4)

    

Net Loss(5)

2024

 

$

1,445,135

 

$

1,632,066

 

$

779,312

 

$

382,728

 

$

1,348,674

 

$

1,387,635

 

$

17.06

 

$

(132,065,000)

2023

 

$

 

$

 

$

7,157,681

 

$

(1,539,940)

 

$

2,334,000

 

$

(1,641,762)

 

$

7.22

 

$

(88,481,000)

2022

 

$

5,836,727

 

$

6,651,810

 

$

 

$

 

$

3,124,517

 

$

3,356,375

 

$

108.32

 

$

(86,908,000)

(1)For 2024, Dr. Manion served as the PEO until January 16, 2024 and Dr. Walker served as the PEO from and after January 17, 2024. For 2023, the PEO was Dr. Manion. For 2022, the PEO was Dr. Walker. For 2024, the non-PEO NEOs were Dr. Davis and Mr. Balthaser. For 2023, the non-PEO NEOs were Mr. Balthaser, Dr. Monahan, Gail Cawkwell, a former executive officer, and Mr. Loerop. For 2022, the non-PEO NEOs were Dr. Cawkwell, Dr. Manion, Dr. Monahan and a former executive officer, Frank Ruffo.
(2)The amounts shown in this column are the amounts of total compensation reported for the PEO, or the average total compensation reported for the non-PEO NEOs, as applicable, for each corresponding year in the “Total” column of the SCT. Please refer to “Summary Compensation Table.”
(3)The amounts shown have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation actually realized or received by the Company’s PEO and non-PEO NEOs. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to the PEO’s total compensation, or the average total compensation of the non-PEO NEOs, as applicable, as reported in the “Total” column in the SCT for the applicable year:

    

PEO (Dr. Walker)

    

PEO (Dr. Manion)

2022

    

2024

2023

    

2024

PEO SCT Reported Total Compensation

$

5,836,727

$

1,445,135

$

7,157,681

$

779,312

Aggregate SCT Reported Equity Compensation(a) (-)

$

4,881,039

$

591,986

$

6,346,481

$

Year-End Fair Value of Awards Granted During the FY & Outstanding (b)(i)(+)

$

5,005,765

$

387,525

$

338,899

$

Year-Over-Year Change in Fair Value of Awards Granted During Prior FY & Outstanding(b)(ii) (+)

$

566,524

$

$

(2,335,318)

$

Vesting Date Fair Value of Awards Granted & Vested During the Covered FY(b)(iii) (+)

$

$

488,170

$

$

Year-Over-Year Change in Fair Value of Awards Granted During Prior FY & Vesting During Covered FY(b)(iv) (+)

$

123,834

$

30,834

$

(354,721)

$

(1,052)

Prior FYE Value of Awards Determined to Fail to Meet Vesting Conditions During Covered FY(b)(v) (-)

$

$

127,612

$

$

395,531

PEO Compensation Actually Paid Determination

$

6,651,810

$

1,632,066

$

(1,539,940)

$

382,728

    

2022

    

2023

    

2024

Non-PEO NEOs Average SCT Reported Total Compensation

$

3,124,517

$

2,334,000

$

1,348,674

Average Aggregate SCT Reported Equity Compensation(a) (-)

$

2,660,870

$

1,762,912

$

963,599

Average Year-End Fair Value of Awards Granted During the FY & Outstanding (b)(i)(+)

$

2,761,495

$

94,139

$

839,007

Average Year-Over-Year Change in Fair Value of Awards Granted During Prior FY & Outstanding(b)(ii) (+)

$

115,987

$

(2,058,062)

$

70,900

Average Vesting Date Fair Value of Awards Granted & Vested During the Covered FY(b)(iii) (+)

$

$

$

91,450

Average Year-Over-Year Change in Fair Value of Awards Granted During Prior FY & Vesting During Covered FY(b)(iv) (+)

$

15,246

$

(248,926)

$

1,203

Non-PEO NEOs Average Compensation Actually Paid Determination

$

3,356,375

$

(1,641,762)

$

1,387,635

(a)The reported grant date fair value of equity awards represents the total of the amounts reported for the PEO, or the average of the total amounts reported in the case of the non-PEO NEOs, as applicable, in the “Option Awards” and “Stock Awards” columns in the SCT for the applicable year.
(b)The equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of, the following for the PEO, or the average of the following in the case of the non-PEO NEOs, to the extent applicable: (i) the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in any prior year that are outstanding and unvested as of the end of the applicable year; (iii) for awards that are granted and vest in the same applicable year, the fair value as of the vesting date; (iv) for awards granted in any prior year that vested in the applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v) for awards granted in any prior year that failed to meet the applicable vesting conditions during the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi) the dollar value of any dividends or other earnings paid on stock or option awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the applicable year.
(4)Cumulative total shareholder return (“TSR”) is calculated by dividing the sum of the cumulative amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between the share price of our common stock at the end and the beginning of the measurement period by the share price of our common stock at the beginning of the measurement period. We have never declared or paid any dividends on our common stock.
(5)The dollar amounts reported represent the amount of net loss reflected in our audited financial statements for the applicable year.
   
Named Executive Officers, Footnote    
(1)For 2024, Dr. Manion served as the PEO until January 16, 2024 and Dr. Walker served as the PEO from and after January 17, 2024. For 2023, the PEO was Dr. Manion. For 2022, the PEO was Dr. Walker. For 2024, the non-PEO NEOs were Dr. Davis and Mr. Balthaser. For 2023, the non-PEO NEOs were Mr. Balthaser, Dr. Monahan, Gail Cawkwell, a former executive officer, and Mr. Loerop. For 2022, the non-PEO NEOs were Dr. Cawkwell, Dr. Manion, Dr. Monahan and a former executive officer, Frank Ruffo.
   
Adjustment To PEO Compensation, Footnote    
(3)The amounts shown have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation actually realized or received by the Company’s PEO and non-PEO NEOs. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to the PEO’s total compensation, or the average total compensation of the non-PEO NEOs, as applicable, as reported in the “Total” column in the SCT for the applicable year:

    

PEO (Dr. Walker)

    

PEO (Dr. Manion)

2022

    

2024

2023

    

2024

PEO SCT Reported Total Compensation

$

5,836,727

$

1,445,135

$

7,157,681

$

779,312

Aggregate SCT Reported Equity Compensation(a) (-)

$

4,881,039

$

591,986

$

6,346,481

$

Year-End Fair Value of Awards Granted During the FY & Outstanding (b)(i)(+)

$

5,005,765

$

387,525

$

338,899

$

Year-Over-Year Change in Fair Value of Awards Granted During Prior FY & Outstanding(b)(ii) (+)

$

566,524

$

$

(2,335,318)

$

Vesting Date Fair Value of Awards Granted & Vested During the Covered FY(b)(iii) (+)

$

$

488,170

$

$

Year-Over-Year Change in Fair Value of Awards Granted During Prior FY & Vesting During Covered FY(b)(iv) (+)

$

123,834

$

30,834

$

(354,721)

$

(1,052)

Prior FYE Value of Awards Determined to Fail to Meet Vesting Conditions During Covered FY(b)(v) (-)

$

$

127,612

$

$

395,531

PEO Compensation Actually Paid Determination

$

6,651,810

$

1,632,066

$

(1,539,940)

$

382,728

(a)The reported grant date fair value of equity awards represents the total of the amounts reported for the PEO, or the average of the total amounts reported in the case of the non-PEO NEOs, as applicable, in the “Option Awards” and “Stock Awards” columns in the SCT for the applicable year.
(b)The equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of, the following for the PEO, or the average of the following in the case of the non-PEO NEOs, to the extent applicable: (i) the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in any prior year that are outstanding and unvested as of the end of the applicable year; (iii) for awards that are granted and vest in the same applicable year, the fair value as of the vesting date; (iv) for awards granted in any prior year that vested in the applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v) for awards granted in any prior year that failed to meet the applicable vesting conditions during the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi) the dollar value of any dividends or other earnings paid on stock or option awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the applicable year.
   
Non-PEO NEO Average Total Compensation Amount     $ 1,348,674 $ 2,334,000 $ 3,124,517
Non-PEO NEO Average Compensation Actually Paid Amount     $ 1,387,635 (1,641,762) 3,356,375
Adjustment to Non-PEO NEO Compensation Footnote    
(3)The amounts shown have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation actually realized or received by the Company’s PEO and non-PEO NEOs. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to the PEO’s total compensation, or the average total compensation of the non-PEO NEOs, as applicable, as reported in the “Total” column in the SCT for the applicable year:

    

2022

    

2023

    

2024

Non-PEO NEOs Average SCT Reported Total Compensation

$

3,124,517

$

2,334,000

$

1,348,674

Average Aggregate SCT Reported Equity Compensation(a) (-)

$

2,660,870

$

1,762,912

$

963,599

Average Year-End Fair Value of Awards Granted During the FY & Outstanding (b)(i)(+)

$

2,761,495

$

94,139

$

839,007

Average Year-Over-Year Change in Fair Value of Awards Granted During Prior FY & Outstanding(b)(ii) (+)

$

115,987

$

(2,058,062)

$

70,900

Average Vesting Date Fair Value of Awards Granted & Vested During the Covered FY(b)(iii) (+)

$

$

$

91,450

Average Year-Over-Year Change in Fair Value of Awards Granted During Prior FY & Vesting During Covered FY(b)(iv) (+)

$

15,246

$

(248,926)

$

1,203

Non-PEO NEOs Average Compensation Actually Paid Determination

$

3,356,375

$

(1,641,762)

$

1,387,635

(a)The reported grant date fair value of equity awards represents the total of the amounts reported for the PEO, or the average of the total amounts reported in the case of the non-PEO NEOs, as applicable, in the “Option Awards” and “Stock Awards” columns in the SCT for the applicable year.
(b)The equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of, the following for the PEO, or the average of the following in the case of the non-PEO NEOs, to the extent applicable: (i) the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in any prior year that are outstanding and unvested as of the end of the applicable year; (iii) for awards that are granted and vest in the same applicable year, the fair value as of the vesting date; (iv) for awards granted in any prior year that vested in the applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v) for awards granted in any prior year that failed to meet the applicable vesting conditions during the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi) the dollar value of any dividends or other earnings paid on stock or option awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the applicable year.
   
Compensation Actually Paid vs. Total Shareholder Return    

Compensation Actually Paid and Cumulative TSR of the Company

The following graph illustrates the relationship of the CAP for our PEOs and non-PEO NEOs, as calculated pursuant to SEC rules, to our cumulative TSR over the three years presented in the Pay Versus Performance table.

Graphic

   
Compensation Actually Paid vs. Net Income    

Compensation Actually Paid and Net Loss

The following graph illustrates the relationship of the CAP for our PEOs and non-PEO NEOs, as calculated pursuant to SEC rules, to our net loss over the three years presented in the Pay Versus Performance table.

Graphic

   
Total Shareholder Return Amount     $ 17.06 7.22 108.32
Net Income (Loss)     (132,065,000) (88,481,000) (86,908,000)
PEO Name Dr. Manion Dr. Walker      
Dr. Walker          
Pay vs Performance Disclosure          
PEO Total Compensation Amount     1,445,135   5,836,727
PEO Actually Paid Compensation Amount     1,632,066   6,651,810
Dr. Manion          
Pay vs Performance Disclosure          
PEO Total Compensation Amount     779,312 7,157,681  
PEO Actually Paid Compensation Amount     382,728 (1,539,940)  
PEO | Dr. Walker | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount     (591,986)   (4,881,039)
PEO | Dr. Walker | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount     387,525   5,005,765
PEO | Dr. Walker | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount         566,524
PEO | Dr. Walker | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount     488,170    
PEO | Dr. Walker | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount     30,834   123,834
PEO | Dr. Walker | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount     (127,612)    
PEO | Dr. Manion | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount       (6,346,481)  
PEO | Dr. Manion | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount       338,899  
PEO | Dr. Manion | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount       (2,335,318)  
PEO | Dr. Manion | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount     (1,052) (354,721)  
PEO | Dr. Manion | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount     (395,531)    
Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount     (963,599) (1,762,912) (2,660,870)
Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount     839,007 94,139 2,761,495
Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount     70,900 (2,058,062) 115,987
Non-PEO NEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount     91,450    
Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount     $ 1,203 $ (248,926) $ 15,246